We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Vaccine Against COVID-19 Advances to Late-stage Development

Product News   Jun 23, 2020

 
Vaccine Against COVID-19 Advances to Late-stage Development
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine

Product News

Intravacc and Celonic have announced that they have signed a research agreement to further design, develop and produce a COVID-19 vaccine based on an immunogenic Spike (S) protein of SARS-CoV-2 combined with Intravacc’s proprietary Outer Membrane Vesicle (OMV) technology.

READ MORE

Medidata Supports Moderna’s COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform

Product News

Medidata is collaborating with Moderna, Inc. to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

READ MORE

Tailored Solutions for Exosome-related Research

Product News

AMSBIO is offering a comprehensive range of end-to-end services for exosome purification, characterization, and engineering.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE